Keenova Therapeutics plc Debt Instrument, Face Amount
Keenova Therapeutics plc had Debt Instrument, Face Amount of $2.47 billion as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-11
- 2026-06-30: Debt Instrument, Face Amount $2.47B.
- 2026-03-31: Debt Instrument, Face Amount $2.48B.
- 2025-12-31: Debt Instrument, Face Amount $2.48B.
- 2025-09-26: Debt Instrument, Face Amount $3.69B.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2026-06-30 | $2.47B 10-Q · filed 2026-08-11 |
| 2026-03-31 | $2.48B 10-Q · filed 2026-05-12 |
| 2025-12-31 | $2.48B 10-Q · filed 2026-08-11 |
| 2025-09-26 | $3.69B 10-Q · filed 2025-11-10 |
| 2025-06-27 | $863.60M 10-Q · filed 2025-08-06 |
| 2025-03-28 | $864.60M 10-Q · filed 2025-05-12 |
| 2024-12-27 | $865.60M 10-K · filed 2026-04-15 |
| 2024-09-27 | $1.64B 10-Q · filed 2024-11-05 |
| 2024-06-28 | $1.64B 10-Q · filed 2024-08-06 |
| 2024-03-29 | $1.65B 10-Q · filed 2024-05-09 |
| 2023-12-29 | $1.65B 10-K · filed 2025-03-13 |
| 2023-06-30 | $3.51B 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.52B 10-Q · filed 2023-05-09 |
| 2022-12-30 | $3.53B 10-K · filed 2024-03-26 |
| 2022-09-30 | $3.58B 10-Q · filed 2022-11-08 |
| 2022-07-01 | $3.60B 10-Q · filed 2022-08-11 |